VanEck Biotech ETF
BBH
BBH
84 hedge funds and large institutions have $87.5M invested in VanEck Biotech ETF in 2018 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 24 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
1% more funds holding
Funds holding: 83 → 84 (+1)
46% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 24
Holders
84
Holding in Top 10
–
Calls
$1.9M
Puts
$436K
Top Buyers
| 1 | +$8.99M | |
| 2 | +$4.5M | |
| 3 | +$3.59M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$3.36M |
| 5 |
Jane Street
New York
|
+$1.18M |
Top Sellers
| 1 | -$830K | |
| 2 | -$540K | |
| 3 | -$432K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$422K |
| 5 |
MCM
Murphy Capital Management
Bedminster,
New Jersey
|
-$412K |